Pharmaceutical ProductCached Profile

BULKAMID

Active Ingredients (Generic):Unmapped
Therapeutic Area: Urology
LIFETIME PROMOTIONAL SPEND
$125,128
General Payments Aggregated (2021–2024)
Data coverage: 2021 – 2024  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

FDA Patient Safety Profile

Dynamic safety indicators compiled from official FDA product labels.

Active Clinical Trials

Clinical studies listing this drug as an active intervention.

Top Funded Physicians (Cumulative)

Doctors receiving the highest aggregate promotional support for this product.

Dr. ESTHER HANDoctor of Osteopathy$7,532
Dr. AMOS ADELOWOMedical Doctor$2,018
Dr. MICHAEL BELSANTEMedical Doctor$1,874
Dr. HIMANSHU AGGARWALMedical Doctor$1,613
Dr. RICHARD LOTENFOEMedical Doctor$1,606

Drug Marketing Payments Log

Federal registry records of promotional speaking, consulting, meals, and offsets.

Year:
2024
2024
2023
2022
2021

Querying Open Payments Database

Fetching live CMS.gov records for BULKAMID...